Myriad Genetics
MYGN
MYGN
258 hedge funds and large institutions have $2.75B invested in Myriad Genetics in 2018 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 76 increasing their positions, 95 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2.68% less ownership
Funds ownership: 107.76% → 105.08% (-2.7%)
20% less repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 95
Holders
258
Holding in Top 10
1
Calls
$8.79M
Puts
$6.51M
Top Buyers
| 1 | +$25.8M | |
| 2 | +$19.3M | |
| 3 | +$14.9M | |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$13.6M |
| 5 |
Millennium Management
New York
|
+$10.9M |
Top Sellers
| 1 | -$19M | |
| 2 | -$18.9M | |
| 3 | -$17.2M | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$16.7M |
| 5 |
SI
Sensato Investors
San Francisco,
California
|
-$16.4M |